During the developing COVID-19 pandemic, The Nuffield Department of Medicine is taking measures to prevent the spread of the disease.
Departments are instructed by the University’s Registrar to continue to work from home where possible, and manage the return to on site working, based on the University guidelines for risk assessments and work prioritisation.
This is to restrict contact between individuals as far as possible. The University remains open and operating as far as possible with the following restrictions -
Yang Shi has been appointed a Member of the Ludwig Institute for Cancer Research to continue his research into chromatin, RNA modifications and cancer. He joins NDM's Ludwig Institute from Harvard University, and is a world leader in the field of epigenetics, which explores how chemical modifications to chromatin—the combination of DNA and histone proteins—control the organisation and expression of the human genome.
Originally screened live on Friday 22nd May 2020, here is another chance to view the Vice-Chancellor, Professor Louise Richardson, being joined by Professor Richard Cornall, Head of the Nuffield Department of Medicine, to talk about the University's research into the COVID-19 virus.
Dr Le Van Tan and colleagues from OUCRU, Vietnam, demonstrate that 43% of quarantined people who were RT-PCR positive for SARS-CoV-2 were asymptomatic, but potentially contagious. The results emphasize the importance of contact tracing, airport quarantine and RT-PCR screening for SARS-CoV-2 among isolated people in controlling the ongoing pandemic.
Professor Sarah Gilbert has been making and testing vaccines designed to induce T cell responses for ten years, chiefly using antigens from malaria and influenza. Based at the Jenner Institute, several of the vaccines developed in Professor Gilbert’s laboratory have progressed into Clinical Trials.